172 related articles for article (PubMed ID: 27585544)
1. Population-based prevalence of cervical infection with human papillomavirus genotypes 16 and 18 and other high risk types in Tlaxcala, Mexico.
Rudolph SE; Lorincz A; Wheeler CM; Gravitt P; Lazcano-Ponce E; Torres-Ibarra L; León-Maldonado L; Ramírez P; Rivera B; Hernández R; Franco EL; Cuzick J; Méndez-Hernández P; Salmerón J;
BMC Infect Dis; 2016 Sep; 16(1):461. PubMed ID: 27585544
[TBL] [Abstract][Full Text] [Related]
2. Triage strategies in cervical cancer detection in Mexico: methods of the FRIDA Study.
Torres-Ibarra L; Lazcano-Ponce E; Franco EL; Cuzick J; Hernández-Ávila M; Lorincz A; Rivera B; Ramírez P; Mendiola-Pastrana I; Rudolph SE; León-Maldonado L; Hernández R; Barrios E; Gravitt P; Moscicki AB; Schmeler KM; Flores YN; Méndez-Hernández P; Salmerón J;
Salud Publica Mex; 2016 Apr; 58(2):197-210. PubMed ID: 27557378
[TBL] [Abstract][Full Text] [Related]
3. Co-infections of HPV16/18 with other high-risk HPV types and the risk of cervical carcinogenesis: A large population-based study.
Wu P; Xiong H; Yang M; Li L; Wu P; Lazare C; Cao C; Gao P; Meng Y; Zhi W; Lin S; Hu J; Wei J; Ma D; Liu J; Yin P; Xing H
Gynecol Oncol; 2019 Dec; 155(3):436-443. PubMed ID: 31604662
[TBL] [Abstract][Full Text] [Related]
4. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
Song F; Du H; Wang C; Huang X; Wu R;
PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial.
Monsonego J; Cox JT; Behrens C; Sandri M; Franco EL; Yap PS; Huh W
Gynecol Oncol; 2015 Apr; 137(1):47-54. PubMed ID: 25667973
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.
Wheeler CM; Hunt WC; Joste NE; Key CR; Quint WG; Castle PE
J Natl Cancer Inst; 2009 Apr; 101(7):475-87. PubMed ID: 19318628
[TBL] [Abstract][Full Text] [Related]
8. HIGH-RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer: the value of HPV16 and HPV18 genotyping?
Kares S; Veijalainen O; Kholová I; Tirkkonen M; Vuento R; Huhtala H; Tuimala V; Mäenpää J; Kujala P
APMIS; 2019 Nov; 127(11):710-716. PubMed ID: 31403733
[TBL] [Abstract][Full Text] [Related]
9. High frequency of HPV genotypes 59, 66, 52, 51, 39 and 56 in women from Western Mexico.
Molina-Pineda A; López-Cardona MG; Limón-Toledo LP; Cantón-Romero JC; Martínez-Silva MG; Ramos-Sánchez HV; Flores-Miramontes MG; de la Mata-González P; Jave-Suárez LF; Aguilar-Lemarroy A
BMC Infect Dis; 2020 Nov; 20(1):889. PubMed ID: 33238902
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the effectiveness of HPV16/18 infection referred for colposcopy in cervical cancer screening in Northwest of China.
Zhang Q; Zhao M; Cao D; Wei X; Wang L; Li Y; Yang T; Zhao J; Pei M; Jia H; Cao S; Quan S; Yang X
J Med Virol; 2018 Jan; 90(1):165-171. PubMed ID: 28710863
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of partial HPV16/18 genotyping in stratifying HPV-positive women attending routine cervical cancer screening: a population-based cohort study.
Gori S; Battagello J; Gustinucci D; Campari C; Zorzi M; Frayle H; Passamonti B; Sartori G; Bulletti S; Fodero C; Cesarini E; Faggiano R; Del Mistro A
BJOG; 2021 Jul; 128(8):1353-1362. PubMed ID: 33326680
[TBL] [Abstract][Full Text] [Related]
12. Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico.
Torres-Ibarra L; Cuzick J; Lorincz AT; Spiegelman D; Lazcano-Ponce E; Franco EL; Moscicki AB; Mahmud SM; Wheeler CM; Rivera-Paredez B; Hernández-López R; León-Maldonado L; Salmerón J;
JAMA Netw Open; 2019 Nov; 2(11):e1915781. PubMed ID: 31747033
[TBL] [Abstract][Full Text] [Related]
13. HPV16 and HPV18 genotyping triage in young women with borderline cytology or mild dyskaryosis: effect of age on genotype-specific risk of high-grade CIN.
McKenna M; McMenamin M; McDowell A
Cytopathology; 2016 Aug; 27(4):261-8. PubMed ID: 26873051
[TBL] [Abstract][Full Text] [Related]
14. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and genotyping of high risk human papillomavirus in cervical cancer samples from Punjab, Pakistan.
Siddiqa A; Zainab M; Qadri I; Bhatti MF; Parish JL
Viruses; 2014 Jul; 6(7):2762-77. PubMed ID: 25036463
[TBL] [Abstract][Full Text] [Related]
16. Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16/18 and FAM19A4/miR124-2 methylation.
Leeman A; Ebisch RMF; Kasius A; Bosgraaf RP; Jenkins D; van de Sandt MM; de Strooper LMA; Heideman DAM; Snijders PJF; Massuger LFAG; Bekkers RLM; Meijer CJLM; van Kemenade FJ; Quint WGV; Melchers WJG
Gynecol Oncol; 2018 Nov; 151(2):311-318. PubMed ID: 30219239
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
Chang CL; Ho SC; Su YF; Juan YC; Huang CY; Chao AS; Hsu ZS; Chang CF; Fwu CW; Chang TC
Gynecol Oncol; 2021 May; 161(2):429-435. PubMed ID: 33757653
[TBL] [Abstract][Full Text] [Related]
18. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
19. Age-specific occurrence of HPV16- and HPV18-related cervical cancer.
de Sanjose S; Wheeler CM; Quint WGV; Hunt WC; Joste NE; Alemany L; Bosch FX; ; Myers ER; Castle PE
Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1313-1318. PubMed ID: 23632816
[TBL] [Abstract][Full Text] [Related]
20. The ideal strategy for cervical cancer screening in Japan: Result from the Fukui Cervical Cancer Screening Study.
Kurokawa T; Onuma T; Shinagawa A; Chino Y; Kobayashi M; Yoshida Y
Cytopathology; 2018 Aug; 29(4):361-367. PubMed ID: 29768678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]